M. F. Re-Louhau

Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

J. Montero, A. Esparís-Ogando, A. Pandiella, 2014, Oncogene.

Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer

A. Esparís-Ogando, A. Pandiella, A. Sánchez-Fdez, 2021, npj Precision Oncology.

High prevalence of Gammapapillomaviruses (Gamma-PVs) in pre-malignant cutaneous lesions of immunocompetent individuals using a new broad-spectrum primer system, and identification of HPV210, a novel Gamma-PV type.

M. Poljak, E. Stella, B. Kocjan, 2018, Virology.

Assessing Gammapapillomavirus infections of mucosal epithelia with two broad-spectrum PCR protocols

M. Poljak, D. Chouhy, A. Giri, 2020, BMC Infectious Diseases.

MEK5 promotes lung adenocarcinoma

A. Esparís-Ogando, A. Pandiella, M. Sánchez-Martín, 2018, European Respiratory Journal.

Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

J. Montero, A. Esparís-Ogando, A. Pandiella, 2014, Oncogene.